Why Beacon?
Discover how Beacon Psychiatric enables data-driven insight that will accelerate your Psychiatric drug development decisions.
- Validate Psychiatric asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore Psychiatric drug design strategies from delivery system and target organ/cell to emerging target investigations
- Benchmark your research with validated preclinical data (blood-brain barrier penetration data included), including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
- Find the right partners in a competitive market, by tracking new companies, collaborations, and licensing deals, as they emerge
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.
Request Beacon Psychiatric Demonstration
Please submit the form below to request your personalized demonstration of the Beacon Psychiatric platform. A member of our specialized team will be in touch shortly to schedule a time that suits you.
How is Beacon Psychiatric Different?
- A Unique Psychiatric Dataset: Comprehensive & accurate, preclinical and clinical, Psychiatric drug, trial and commercial data to inform your Psychiatric drug development decisions
- In Depth Preclinical Data: Including preclinical publication summaries, and links to conference abstracts and posters
- Proprietary Ontologies: Market leading standardized ontologies, enabling you to easily segment the Psychiatric drug development landscape, to quickly find the data that matters to you
- Human Intelligence: Beacon Psychiatric data is manually curated by sector specialist analysts, to ensure data accuracy and integrity
Search